European Markets for Diabetes Monitoring, Treatment and Drug Delivery
The European market for diabetes diagnosis, treatment and drug delivery is expected to exceed €7.7 billion by 2019.
This market includes traditional blood glucose meters, continuous glucose monitoring systems, blood glucose test strips, lancets and lancing devices, insulin, insulin syringes, insulin pens and insulin pumps. Market growth is expected to be fuelled by an increasing number of diabetics and improved education regarding the importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population.
Scope: This report pertains to a forecast period of 10 years (2009- 2019) for Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K.
Report Contents:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and secondary research methods.
This market includes traditional blood glucose meters, continuous glucose monitoring systems, blood glucose test strips, lancets and lancing devices, insulin, insulin syringes, insulin pens and insulin pumps. Market growth is expected to be fuelled by an increasing number of diabetics and improved education regarding the importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population.
Scope: This report pertains to a forecast period of 10 years (2009- 2019) for Austria, Belgium, Denmark, Finland, France, Germany, Italy, Luxembourg, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, U.K.
Report Contents:
- Competitor Analysis
- Identified Strategic Opportunities
- Market Overview by Segment & Country
- Trend Analysis by Segment & Country
- Market Drivers & Limiters
- Mergers & Acquisitions
- Customer Feedback and Market Monitoring
- Traditional blood glucose monitoring
- Blood glucose meters
- Blood glucose test strips
- Lancets and lancing devices
- Insulin
- Insulin syringes
- Insulin pens
- Insulin pumps
- Artificial pancreas
- Sanofi
- Johnson & Johnson
- Eli Lilly
- Abbott
- Roche
- Bayer
- Medtronic
- Menarini
- Artsana
- Becton Dickinson
- Terumo
- Sooil
- B Braun
- Dexcom
- Novo Nordisk
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and secondary research methods.
EXECUTIVE SUMMARY
1.1 EUROPEAN MARKETS FOR DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY
1.2 TRADITIONAL BLOOD GLUCOSE MONITORING MARKET
1.3 CONTINUOUS GLUCOSE MONITORING MARKET
1.4 INSULIN MARKET
1.5 INSULIN PEN MARKET
1.6 INSULIN SYRINGE MARKET
1.7 INSULIN PUMP MARKET
1.8 LEADING COMPETITORS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
EUROPEAN DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY MARKET
3.1 INTRODUCTION
3.1.1 Types of Diabetes
3.1.1.1 Type 1 Diabetes
3.1.1.2 Type 2 Diabetes
3.1.1.3 Gestational Diabetes
3.1.1.4 Prediabetes
3.1.2 Diabetes Complications
3.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
3.1.4 Signs and Symptoms
3.1.5 Diabetes Monitoring
3.1.5.1 Initial Diagnosis
3.1.5.2 Blood Glucose Monitoring Systems
3.1.5.3 Urinary Glucose Monitoring
3.1.5.4 Noninvasive and Minimally Invasive Monitoring Devices
3.1.6 Treatment
3.1.6.1 Lifestyle Measures
3.1.6.2 Insulin
3.1.6.3 Insulin Types
3.1.6.4 Oral Antidiabetic Drugs
3.1.6.5 Injectable Antidiabetic Drugs
3.1.7 Drug Delivery Systems
3.1.7.1 Insulin Syringes
3.1.7.2 Insulin Pens
3.1.7.3 Insulin Pumps
3.1.7.4 Inhaled Insulin
3.2 CURRENCY EXCHANGE RATE
3.3 MARKET OVERVIEW
3.4 TREND ANALYSIS BY SEGMENT
3.5 MARKET DRIVERS AND LIMITERS
3.5.1 Market Drivers
3.5.2 Market Limiters
3.6 COMPETITIVE ANALYSIS
3.6.1 Leading Competitors
3.6.2 Market Concentration
3.7 MERGERS AND ACQUISITIONS
COUNTRY PROFILES
4.1 INTRODUCTION
4.1.1 Population
4.1.2 GDP per Capita
4.1.3 Units
4.1.4 Price Index
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 ITALY
4.6 SPAIN
4.7 BENELUX
4.8 SCANDINAVIA
4.9 AUSTRIA
4.10 SWITZERLAND
4.11 PORTUGAL
TRADITIONAL BLOOD GLUCOSE MONITORING MARKET
5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
5.4 MARKET DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
BLOOD GLUCOSE METER MARKET
6.1 INTRODUCTION
6.2 MARKET ANALYSIS AND FORECAST
6.3 MARKET DRIVERS AND LIMITERS
6.3.1 Market Drivers
6.3.2 Market Limiters
6.4 COMPETITIVE ANALYSIS
BLOOD GLUCOSE TEST STRIP MARKET
7.1 INTRODUCTION
7.2 MARKET ANALYSIS AND FORECAST
7.3 MARKET DRIVERS AND LIMITERS
7.3.1 Market Drivers
7.3.2 Market Limiters
7.4 COMPETITIVE ANALYSIS
LANCET AND LANCING DEVICE MARKET
8.1 INTRODUCTION
8.2 MARKET ANALYSIS AND FORECAST
8.3 MARKET DRIVERS AND LIMITERS
8.3.1 Market Drivers
8.3.2 Market Limiters
8.4 COMPETITIVE ANALYSIS
CONTINUOUS GLUCOSE MONITORING MARKET
9.1 INTRODUCTION
9.2 MARKET OVERVIEW
9.2.1 Total CGM Market
9.2.2 Emerging Markets: Non-Invasive CGM
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Total CGM Market
9.3.2 CGM System Market
9.3.3 CGM Sensor Market
9.4 MARKET DRIVERS AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE ANALYSIS
INSULIN MARKET
10.1 INTRODUCTION
10.1.1 Insulin Types
10.2 MARKET ANALYSIS AND FORECAST
10.3 MARKET DRIVERS AND LIMITERS
10.3.1 Market Drivers
10.3.2 Market Limiters
10.4 COMPETITIVE ANALYSIS
INSULIN PEN MARKET
11.1 INTRODUCTION
11.2 MARKET ANALYSIS AND FORECAST
11.3 MARKET DRIVERS AND LIMITERS
11.3.1 Market Drivers
11.3.2 Market Limiters
11.4 COMPETITIVE ANALYSIS
INSULIN SYRINGE MARKET
12.1 INTRODUCTION
12.2 MARKET ANALYSIS AND FORECAST
12.3 MARKET DRIVERS AND LIMITERS
12.3.1 Market Drivers
12.3.2 Market Limiters
12.4 COMPETITIVE ANALYSIS
INSULIN PUMP MARKET
13.1 INTRODUCTION
13.2 MARKET OVERVIEW
13.3 MARKET ANALYSIS AND FORECAST
13.3.1 Total Traditional Insulin Pump Market
13.3.1.1 Traditional Insulin Pump Market
13.3.1.2 Infusion Set Market
13.3.2 Emerging Markets: Patch Pump Market
13.3.2.1 Patch Pump PDM Market
13.3.2.2 Insulin Pod Market
13.3.3 Emerging Markets: Simple Pump Market
13.4 MARKET DRIVERS AND LIMITERS
13.4.1 Market Drivers
13.4.2 Market Limiters
13.5 COMPETITIVE ANALYSIS
13.5.1 Traditional Pump Market Competitors
13.5.2 Patch Pump Market Competitors
13.5.3 Emerging Competitors
APPENDIX 1: ARTIFICIAL PANCREAS
14.1 MECHANICAL ARTIFICIAL PANCREAS
14.2 BIO-ARTIFICIAL PANCREAS
ABBREVIATIONS
1.1 EUROPEAN MARKETS FOR DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY
1.2 TRADITIONAL BLOOD GLUCOSE MONITORING MARKET
1.3 CONTINUOUS GLUCOSE MONITORING MARKET
1.4 INSULIN MARKET
1.5 INSULIN PEN MARKET
1.6 INSULIN SYRINGE MARKET
1.7 INSULIN PUMP MARKET
1.8 LEADING COMPETITORS
RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
EUROPEAN DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY MARKET
3.1 INTRODUCTION
3.1.1 Types of Diabetes
3.1.1.1 Type 1 Diabetes
3.1.1.2 Type 2 Diabetes
3.1.1.3 Gestational Diabetes
3.1.1.4 Prediabetes
3.1.2 Diabetes Complications
3.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes
3.1.4 Signs and Symptoms
3.1.5 Diabetes Monitoring
3.1.5.1 Initial Diagnosis
3.1.5.2 Blood Glucose Monitoring Systems
3.1.5.3 Urinary Glucose Monitoring
3.1.5.4 Noninvasive and Minimally Invasive Monitoring Devices
3.1.6 Treatment
3.1.6.1 Lifestyle Measures
3.1.6.2 Insulin
3.1.6.3 Insulin Types
3.1.6.4 Oral Antidiabetic Drugs
3.1.6.5 Injectable Antidiabetic Drugs
3.1.7 Drug Delivery Systems
3.1.7.1 Insulin Syringes
3.1.7.2 Insulin Pens
3.1.7.3 Insulin Pumps
3.1.7.4 Inhaled Insulin
3.2 CURRENCY EXCHANGE RATE
3.3 MARKET OVERVIEW
3.4 TREND ANALYSIS BY SEGMENT
3.5 MARKET DRIVERS AND LIMITERS
3.5.1 Market Drivers
3.5.2 Market Limiters
3.6 COMPETITIVE ANALYSIS
3.6.1 Leading Competitors
3.6.2 Market Concentration
3.7 MERGERS AND ACQUISITIONS
COUNTRY PROFILES
4.1 INTRODUCTION
4.1.1 Population
4.1.2 GDP per Capita
4.1.3 Units
4.1.4 Price Index
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 ITALY
4.6 SPAIN
4.7 BENELUX
4.8 SCANDINAVIA
4.9 AUSTRIA
4.10 SWITZERLAND
4.11 PORTUGAL
TRADITIONAL BLOOD GLUCOSE MONITORING MARKET
5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
5.4 MARKET DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS
BLOOD GLUCOSE METER MARKET
6.1 INTRODUCTION
6.2 MARKET ANALYSIS AND FORECAST
6.3 MARKET DRIVERS AND LIMITERS
6.3.1 Market Drivers
6.3.2 Market Limiters
6.4 COMPETITIVE ANALYSIS
BLOOD GLUCOSE TEST STRIP MARKET
7.1 INTRODUCTION
7.2 MARKET ANALYSIS AND FORECAST
7.3 MARKET DRIVERS AND LIMITERS
7.3.1 Market Drivers
7.3.2 Market Limiters
7.4 COMPETITIVE ANALYSIS
LANCET AND LANCING DEVICE MARKET
8.1 INTRODUCTION
8.2 MARKET ANALYSIS AND FORECAST
8.3 MARKET DRIVERS AND LIMITERS
8.3.1 Market Drivers
8.3.2 Market Limiters
8.4 COMPETITIVE ANALYSIS
CONTINUOUS GLUCOSE MONITORING MARKET
9.1 INTRODUCTION
9.2 MARKET OVERVIEW
9.2.1 Total CGM Market
9.2.2 Emerging Markets: Non-Invasive CGM
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Total CGM Market
9.3.2 CGM System Market
9.3.3 CGM Sensor Market
9.4 MARKET DRIVERS AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE ANALYSIS
INSULIN MARKET
10.1 INTRODUCTION
10.1.1 Insulin Types
10.2 MARKET ANALYSIS AND FORECAST
10.3 MARKET DRIVERS AND LIMITERS
10.3.1 Market Drivers
10.3.2 Market Limiters
10.4 COMPETITIVE ANALYSIS
INSULIN PEN MARKET
11.1 INTRODUCTION
11.2 MARKET ANALYSIS AND FORECAST
11.3 MARKET DRIVERS AND LIMITERS
11.3.1 Market Drivers
11.3.2 Market Limiters
11.4 COMPETITIVE ANALYSIS
INSULIN SYRINGE MARKET
12.1 INTRODUCTION
12.2 MARKET ANALYSIS AND FORECAST
12.3 MARKET DRIVERS AND LIMITERS
12.3.1 Market Drivers
12.3.2 Market Limiters
12.4 COMPETITIVE ANALYSIS
INSULIN PUMP MARKET
13.1 INTRODUCTION
13.2 MARKET OVERVIEW
13.3 MARKET ANALYSIS AND FORECAST
13.3.1 Total Traditional Insulin Pump Market
13.3.1.1 Traditional Insulin Pump Market
13.3.1.2 Infusion Set Market
13.3.2 Emerging Markets: Patch Pump Market
13.3.2.1 Patch Pump PDM Market
13.3.2.2 Insulin Pod Market
13.3.3 Emerging Markets: Simple Pump Market
13.4 MARKET DRIVERS AND LIMITERS
13.4.1 Market Drivers
13.4.2 Market Limiters
13.5 COMPETITIVE ANALYSIS
13.5.1 Traditional Pump Market Competitors
13.5.2 Patch Pump Market Competitors
13.5.3 Emerging Competitors
APPENDIX 1: ARTIFICIAL PANCREAS
14.1 MECHANICAL ARTIFICIAL PANCREAS
14.2 BIO-ARTIFICIAL PANCREAS
ABBREVIATIONS
